What they were paid
CG Oncology Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $62,582 | $0 | $412,627 | — | $475,209 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CG Oncology, Inc. DEF 14A filed April 24, 2026, accession 0001193125-26-177395, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025CG Oncology pays directors a $45,000 cash retainer and $412,627 in equity.
The rest of the CG Oncology board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Arthur Kuan | Chair of the Board | $0 |
| Brian Liu, M.D | Independent Director | $475,127 |
| Christina Rossi | Independent Director | $575,150 |
| James J. Mulé, Ph.D | Independent Director | $457,627 |
| Leonard Post, Ph.D | Lead Independent Director | $500,127 |
| Susan Graf | Independent Director | $482,627 |
| Victor Tong, Jr | Independent Director | $467,627 |
The full CG Oncology compensation record
free company briefThis page is one director within CG Oncology's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat